Subscribe to RSS
DOI: 10.1055/s-0032-1316336
Wie wirken sich somatoforme und depressive Symptome und Syndrome auf die Lebenszufriedenheit aus? Ergebnisse einer bevölkerungsrepräsentativen Befragung in Deutschland
How do Somatoform and Depressive Symptoms and Syndromes Affect Life Satisfaction? Results from a Representative Population Survey in GermanyPublication History
eingereicht 22 December 2011
akzeptiert 30 May 2012
Publication Date:
06 February 2013 (online)
![](https://www.thieme-connect.de/media/ppmp/201306/lookinside/thumbnails/10.1055-s-0032-1316336-1.jpg)
Zusammenfassung
Hintergrund:
Die differenzielle Bedeutung depressiver und somatoformer Symptome/Syndrome für die Lebenszufriedenheit in der Allgemeinbevölkerung wird untersucht.
Material und Methoden:
In einer bevölkerungsrepräsentativen Stichprobe (N=2 510) werden somatische und depressive Symptome mit dem Patient Health Questionnaire (PHQ) und Lebenszufriedenheit mit den Fragen zur Lebenszufriedenheit (FLZM) erhoben.
Ergebnisse:
Sowohl depressive und somatoforme Syndrome als auch subklinische depressive und somatische Symptome beeinflussen die Lebenszufriedenheit negativ. Während depressive Symptome/Syndrome alle Bereiche der Lebenszufriedenheit einschränken, zeigen somatische Symptome/somatoforme Syndrome ein differenziertes Zusammenhangsmuster.
Schlussfolgerung:
Unter Berücksichtigung komorbider depressiver Symptome/Syndrome wirken sich somatische Symptome und somatoforme Syndrome nur auf einige Bereiche der Lebenszufriedenheit negativ aus. Eine dimensionale Auswertung ist sinnvoll, um den Einfluss subklinischer Symptome zu beschreiben.
Abstract
Objectives:
The aim of this study is to investigate the differential impact of somatoform and depressive symptoms/syndromes on life satisfaction.
Methods:
In a representative population survey in Germany (N=2 510) depressive and somatic symptoms are screened with the Patient Health Questionnaire (PHQ), Life satisfaction is assessed with the Questions on Life Satisfaction (FLZM).
Results:
Both subclinical depressive/somatic symptoms and clinically relevant depressive/somatoform syndromes are associated with decreased life satisfaction. Depressive symptoms/syndromes result in lower satisfaction in all areas of life, whereas somatic symptoms/somatoform syndromes only affect certain domains of life satisfaction.
Conclusions:
Considering comorbid depressive symptoms/syndromes, somatic symptoms and somatoform syndromes show negative associations with only some of the subdimensions of life satisfaction. A dimensional approach is useful to consider the effects of subclinical symptoms on life satisfaction.
-
Literatur
- 1 Moons P, Budts W, De Geest S. Critique on the conceptualisation of quality of life: a review and evaluation of different conceptual approaches. Int J Nurs Stud 2006; 43: 891-901
- 2 Koller M, Lorenz W. Survival of the quality of life concept. Br J Surg 2003; 90: 1175-1177
- 3 Ravens-Sieberer U, Wille N, Nickel J et al. Wohlbefinden und gesundheitsbezogene Lebensqualität aus einer bevölkerungsbezogenen Perspektive – Ergebnisse aus aktuellen internationalen und nationalen Studien. Z Gesundheitspsychol 2009; 17: 56-68
- 4 Bullinger M. Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research. Restor Neurol Neurosci 2002; 20: 93-101
- 5 Daig I, Lehmann A. Verfahren zur Messung der Lebensqualität. Z Med Psychol 2007; 16: 5-23
- 6 Anderson KL, Burckhardt CS. Conceptualization and measurement of quality of life as an outcome variable for health care intervention and research. J Adv Nurs 1999; 29: 298-306
- 7 Goldbeck L, Schmitz TG, Besier T et al. Life satisfaction decreases during adolescence. Qual Life Res 2007; 16: 969-979
- 8 Henrich G, Herschbach P. Questions on Life Satisfaction (FLZM) – A short questionnaire for assessing subjective quality of life. Eur J Psychol Assess 2000; 16: 150-159
- 9 Weller I. Beachtliche Unterschiede in der Lebenszufriedenheit zwischen den Ländern der Europäischen Union: eine Untersuchung auf der Basis des Eurobarometers. Informationsdienst Soziale Indikatoren 1997; DOI: 10-12.
- 10 Hiller W, Rief W, Brähler E. Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 2006; 41: 704-712
- 11 Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357-376
- 12 Ladwig KH, Marten-Mittag B, Erazo N et al. Identifying somatization disorder in a population-based health examination survey: psychosocial burden and gender differences. Psychosomatics 2001; 42: 511-518
- 13 Faravelli C, Salvatori S, Galassi F et al. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 24-29
- 14 Grabe HJ, Meyer C, Hapke U et al. Specific somatoform disorder in the general population. Psychosomatics 2003; 44: 304-311
- 15 World Health Organisation . The global Burden of Disease: 2004 Update. Geneva: WHO Library Cataloguing-in-Publication Data; 2008
- 16 Moussavi S, Chatterji S, Verdes E et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. The Lancet 2007; 370: 851-858
- 17 Löwe B, Spitzer RL, Williams JB et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 2008; 30: 191-199
- 18 Alonso J, Angermeyer MC, Bernert S et al. Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004; 109: 38-46
- 19 Spitzer RL, Kroenke K, Linzer M et al. Health-related quality of life in primary care patients with mental disorders – results from the PRIME-MD 1000 Study. JAMA 1995; 274: 1511-1517
- 20 Schmidt S, Petermann F, Beutel ME et al. Psychisches Befinden, Beschwerden und Belastungen: Ergebnisse einer repräsentativen Studie. Z Psychiatr Psychol Psychother 2011; 59: 155-165
- 21 Daig I, Herschbach P, Lehmann A et al. Gender and age differences in domain-specific life satisfaction and the impact of depressive and anxiety symptoms: a general population survey from Germany. Qual Life Res 2009; 18: 669-678
- 22 Herschbach P. Das Zufriedenheitsparadox in der Lebensqualitätsforschung. Wovon hängt unser Wohlbefinden ab?. Psychother Psychosom Med Psychol 2002; 52: 141-150
- 23 Goldbeck L, Schmitz TG. Comparison of three generic questionnaires measuring quality of life in adolescents and adults with cystic fibrosis: The 36-item short form health survey, the quality of life profile for chronic diseases, and the questions on life satisfaction. Qual Life Res 2001; 10: 23-36
- 24 Löwe B, Spitzer RL, Zipfel S et al. Gesundheitsfragebogen für Patienten (PHQ − D). 2. Aufl. Karlsruhe: Pfizer; 2002
- 25 Saß H, Wittchen H-U, Zaudig M et al. Diagnostische Kriterien DSM-IV-TR. 1. Aufl. Göttingen: Hogrefe; 2003
- 26 Dilling H. Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V, klinisch diagnostische Leitlinien. 2. Aufl.: Weltgesundheitsorganisation; 1993
- 27 Häuser W, Biewer W, Gesmann M et al. A comparison of the clinical features of fibromyalgia syndrome in different settings. Eur J Pain 2011; 15: 936-941
- 28 Kroenke K, Spitzer RL, Williams JBW et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 2010; 32: 345-359
- 29 Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-266
- 30 Rief W, Martin A, Klaiberg A et al. Specific effects of depression, panic, and somatic symptoms on illness behavior. Psychosom Med 2005; 67: 596-601
- 31 van Ravesteijn H, Wittkampf K, Lucassen P et al. Detecting somatoform disorders in primary care with the PHQ-15. Ann Fam Med 2009; 7: 232-238
- 32 Gräfe K, Zipfel S, Herzog W et al. Screening psychischer Störungen mit dem „Gesundheitsfragebogen für Patienten (PHQ-D)“. Diagnostica 2004; 50: 171-181
- 33 Kroenke K, Spitzer RL, Williams JBW. The PHQ-9 – Validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613
- 34 Löwe B. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 2004; 78: 131-140
- 35 Stein MB, Heimberg RG. Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample. J Affect Disord 2004; 79: 161-166
- 36 Dear K, Henderson S, Korten A. Well-being in Australia – Findings from the National Survey of Mental Health and Well-being. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 503-509
- 37 Rief W, Hiller W. Somatiserungsstörung und Hypochondrie. Göttingen: Hogrefe; 1998
- 38 Kroenke K, Rosmalen JG. Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders. Med Clin North Am 2006; 90: 603-626
- 39 Jackson JL, Kroenke K. Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med 2008; 70: 430-434
- 40 Creed F. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 2004; 56: 391-408
- 41 Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 903-910
- 42 Clarke DM, Piterman L, Byrne CJ et al. Somatic symptoms, hypochondriasis and psychological distress: a study of somatisation in Australian general practice. Med J Aust 2008; 189: 560-564
- 43 Patten SB, Schopflocher D. Longitudinal epidemiology of major depression as assessed by the Brief Patient Health Questionnaire (PHQ-9). Compr Psychiatry 2009; 50: 26-33
- 44 Rief W, Nanke A, Klaiberg A et al. Base rates for panic and depression according to the Brief Patient Health Questionnaire: a population-based study. J Affect Disord 2004; 82: 271-276
- 45 Meyer C, Rumpf HJ, Hapke U et al. Impact of psychiatric disorders in the general population: satisfaction with life and the influence of comorbidity and disorder duration. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 435-441
- 46 Al-Windi A. The influence of complaint symptoms on health care utilisation, medicine use, and sickness absence. A comparison between retrospective and prospective utilisation. J Psychosom Res 2005; 59: 139-146
- 47 Hessel A, Geyer M, Hinz A et al. Inanspruchnahme des Gesundheitssystems wegen somatoformer Beschwerden – Ergebnisse einer bevölkerungsrepräsentativen Befragung. Z Psychosom Med Psychother 2005; 51: 38-56
- 48 Mewes R, Rief W, Brähler E et al. Lower decision threshold for doctor visits as a predictor of health care use in somatoform disorders and in the general population. Gen Hosp Psychiatry 2008; 30: 349-355
- 49 Nanke A, Rief W. Zur Inanspruchnahme medizinischer Leistungen bei Patienten mit somatoformen Störungen. Psychotherapeut 2003; 48: 329-335
- 50 Kapfhammer HP. Somatoforme Störungen Konzept, Klinik, Ätiopathogenese und Therapie. Nervenarzt 2008; 79: 99-115
- 51 Diener E, Suh EM, Lucas RE et al. Subjective well-being: Three decades of progress. Psychol Bull 1999; 125: 276-302
- 52 Sher KJ, Trull TJ. Methodological issues in psychopathology research. Annu Rev Psychol 1996; 47: 371-400
- 53 Aigner M, Forster-Streffleur S, Prause W et al. What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder. Soc Psychiatry Psychiatr Epidemiol 2006; 41: 81-86
- 54 Beck JS. Cognitive Therapy: Basics and Beyond. New York: The Guilford Press; 1995